Pneumococcal Vaccine
978-613-1-96829-7
6131968292
84
2010-08-31
34.00 €
eng
https://images.our-assets.com/cover/230x230/9786131968297.jpg
https://images.our-assets.com/fullcover/230x230/9786131968297.jpg
https://images.our-assets.com/cover/2000x/9786131968297.jpg
https://images.our-assets.com/fullcover/2000x/9786131968297.jpg
A pneumococcal vaccine is a vaccine against Streptococcus pneumoniae. In the USA, a heptavalent pneumococcal conjugate vaccine vaccine (PCV 7) (e.g. Prevenar) is recommended since 2000 for all children aged 2–23 months and for at-risk children aged 24–59 months. The normally 4-doses series is given at 2, 4, 6 & 12–14 months of age. Protection is good against deep pneumococcal infections (especially septicemia and meningitis). Similar 9-, 10-, and 13-valent vaccines have been tested. However, if a child is exposed to a serotype of pneumococcus that is not contained in the vaccine, he/she is not afforded any protection. This limitation, and the ability of capsular-polysaccharide conjugate vaccines to promote the spread of non-covered serotypes, has led to research into vaccines that would provide species-wide protection. Pneumococcal polysaccharide vaccine (Pneumovax is one brand) gives at least 85% protection in those under 55 years of age for five years or longer.
https://morebooks.shop/books/gb/published_by/betascript-publishing/1/products
Clinical disciplines
https://morebooks.shop/store/gb/book/pneumococcal-vaccine/isbn/978-613-1-96829-7